---
title: 'Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory
  multiple myeloma: a phase I/II trial.'
date: '2024-04-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38643278
source: Trending page - PubMed
description: <span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Shi+M&amp;cauthor_id=38643278"
  ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link"
  data-ga-label="Ming Shi">Ming Shi</a><sup class="equal-contrib-container"><span
  class="author-sup-separator">&nbsp;</span><a class="equal-contrib" title="Contributed
  equally" href="https://pubmed.ncbi.nlm.nih.gov/38643278#full-view-equal-contrib-explanation"
  ref="linksrc=author_equal_contrib">#</a></sup><sup class="affiliation-links"><span
  class="author-sup-separator">&nbsp;</span>< ...
disable_comments: true
---
<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Shi+M&amp;cauthor_id=38643278" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="Ming Shi">Ming Shi</a><sup class="equal-contrib-container"><span class="author-sup-separator">&nbsp;</span><a class="equal-contrib" title="Contributed equally" href="https://pubmed.ncbi.nlm.nih.gov/38643278#full-view-equal-contrib-explanation" ref="linksrc=author_equal_contrib">#</a></sup><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span>< ...